Wei Li

Wei Li

Director/Board Member chez OCUMENSION THERAPEUTICS

Fortune : - $ au 31/03/2024

52 ans
Health Technology
Finance
Consumer Services

Profil

Wei Li is currently a Director at Ivenix, Inc., a Director at Shanghai Fangrun Medical Technology Co., Ltd., a Director at Medeor Therapeutics, Inc., a Non-Executive Director at CStone Pharmaceuticals Co. Ltd., a Director at LifeMine Therapeutics, Inc., a Non-Executive Director at Ocumension Therapeutics, a Founding Partner at Creacion Ventures Management LLC, a Manager at Creacion Ventures GP I LLC, and a Board Member at Frontera Therapeutics, Inc. In the past, Dr. Li served as the Chief Executive Officer & Director at AltheaDx, Inc., a Director at Tunitas Therapeutics, Inc., a Director at TCR2 Therapeutics, Inc., a Director at Kymera Therapeutics, Inc., a Director at Dewpoint Therapeutics, Inc., a Principal at Vertex Pharmaceuticals, Inc., an Associate at Robert W.
Baird & Co., Inc., an Executive Partner at Eight Roads Capital Advisors (Hong Kong) Ltd., a Principal at Merck Serono SA, a Board Member at Innovent Biologics, Inc., a Senior Associate at Impresa Management LLC, and a Managing Partner at 6 Dimensions Capital.
Dr. Li's education includes a doctorate from Harvard University, an undergraduate degree from China University of Science & Technology, and an MBA from Kellogg School of Management.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Wei Li

SociétésPosteDébut
CSTONE PHARMACEUTICALS Director/Board Member 01/10/2018
OCUMENSION THERAPEUTICS Director/Board Member 01/04/2018
Director/Board Member 01/12/2019
Private Equity Investor 01/04/2020
Director/Board Member -
Creacion Ventures GP I LLC Corporate Officer/Principal -
Director/Board Member -
Director/Board Member 01/09/2015
Director/Board Member -
Tous les postes actifs de Wei Li

Anciens postes connus de Wei Li

SociétésPosteFin
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Wei Li

Formation de Wei Li

Harvard University Doctorate Degree
China University of Science & Technology Undergraduate Degree
Kellogg School of Management Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Wei Li

Relations

99

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

INNOVENT BIOLOGICS, INC.

Health Technology

CSTONE PHARMACEUTICALS

Health Technology

KYMERA THERAPEUTICS, INC.

Health Technology

OCUMENSION THERAPEUTICS

Health Technology

Entreprise privées16

Health Technology

Health Technology

Finance

Finance

Health Technology

Health Technology

Finance

Finance

Electronic Technology

Health Services

Health Technology

Health Technology

Health Technology

Finance

Creacion Ventures GP I LLC

Health Technology

Voir les connexions sociétés